Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_assertion type Assertion NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_head.
- NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_assertion description "[Intratumoral administration of MV-CEA at a total dose of 6 x 10(6) TCID50 resulted in statistically significant tumor growth delay (P = 0.004) and prolongation of survival (P = 0.001) in a subcutaneous PC-3 xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_provenance.
- NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_assertion evidence source_evidence_literature NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_provenance.
- NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_assertion SIO_000772 18973133 NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_provenance.
- NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_assertion wasDerivedFrom befree-20150227 NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_provenance.
- NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_assertion wasGeneratedBy ECO_0000203 NP309525.RAHnimx0QN2_JHM7AUMXywNasWGlJFusqnyfWGiuE3jK8130_provenance.